Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase 3 1Phase 2 1

Status

Completed 6

Sponsor Class

OTHER 78INDUSTRY 69NIH 12NETWORK 6OTHER_GOV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 6Head and Neck Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Invasive Breast Cancer 1Inflammatory Breast Neoplasms 1Immunoblastic Lymphadenopathy 1Her2 Positive Metastatic Breast Cancer 1Burkitt Lymphoma 1Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 39Docetaxel 30Tamoxifen 29Paclitaxel 27Doxorubicin 26Trastuzumab 20Radiotherapy 18Epirubicin 16Letrozole 13exemestane 11Fluorouracil 11Anastrozole 11Capecitabine 10Bevacizumab 10Immunohistochemistry 9Filgrastim 9Fulvestrant 8Methotrexate 7Gene Expression Profiling 7palbociclib 6Zoledronic Acid 6Microarray Analysis 6Lapatinib 6Goserelin 6Chemotherapy, Adjuvant 6Amplified Fragment Length Polymorphism Analysis 6Vinorelbine 5Triptorelin Pamoate 5Carboplatin 5Absorptiometry, Photon 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms × Lapatinib × Clear all
NCT01526369 2025-05-09

TH V THL

Cancer Trials Ireland

Phase 3 Completed
75 enrolled
Breast

Breast Neoplasms

NCT00424164 2024-03-08

LAPATAM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
20 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01138384 2023-08-04

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 1/2 Completed
19 enrolled
Breast

Breast Neoplasms

NCT01485926 2018-08-06

TCHL Phase II

Cancer Trials Ireland

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms

NCT00450892 2016-07-07

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Completed
129 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00753207 2016-02-15

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

Cancer Trials Ireland

Phase 1 Completed
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡